Drug Trial Radar · NCT05119686
Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients
Last checked: Nov 19, 2026Latest source record: May 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
140
Actual
Start
Nov 16, 2021
Primary completion
Nov 17, 2022
Study completion Nov 17, 2022
Sponsor
- Lead sponsor
- Arthrosi TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Nov 15, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 weeks.
Conditions
- Gout
- Arthritis, Gouty
- Hyperuricemia
- Gout Chronic
Interventions
AR882 Dose 1Drug
Solid Oral Capsule
AR882 Dose 2Drug
Solid Oral Capsule
PlaceboDrug
Matching Solid Oral Capsule Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serum urate (uric acid) (sUA) level < 6 mg/dL following 6 weeks of dosingTime frame: 6 weeks
Locations
23 sites in 3 countries. Site status is shown where the registry gives one.
Arthrosi Investigative Site
Gilbert, Arizona
Arthrosi Investigative Site
Sun City, Arizona
Arthrosi Investigative Site
Tucson, Arizona
Arthrosi Investigative Site
Miami, Florida
Arthrosi Investigative Site
Miami Lakes, Florida
Arthrosi Investigative Site
Tampa, Florida
Arthrosi Investigative Site
Honolulu, Hawaii
Arthrosi Investigative Site
Overland Park, Kansas
Arthrosi Investigative Site
Cleveland, Ohio
Arthrosi Investigative Site
Cleveland, Ohio
Arthrosi Investigative Site
Duncansville, Pennsylvania
Arthrosi Investigative Site
Dallas, Texas
Arthrosi Investigative Site
Houston, Texas
Arthrosi Investigative Site
Tomball, Texas
Arthrosi Investigative Site
West Jordan, Utah
Arthrosi Investigative Site
Glendale, Wisconsin
Arthrosi Investigative Site
Melbourne, Camberwell, Australia
Arthrosi investigative Site
Botany, New South Wales, Australia
Arthrosi Investigative Site
Taichung, Taiwan
Arthrosi Investigative Site - 301
Taipei, Taiwan
Arthrosi Investigative Site - 304
Taipei, Taiwan
Arthrosi Investigative Site
Taipei, Taiwan
Arthrosi Investigative Site
Taoyuan, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.